<DOC>
	<DOCNO>NCT02414477</DOCNO>
	<brief_summary>The purpose study well understand people break tobacco specific cancer-causing toxin call N'-nitrosonornicotine ( NNN ) present smokeless tobacco cigarette . Some people able get rid chemical harmless agent good others . Through research , investigator hope develop well understand people process potentially harmful chemical identify tobacco user danger develop cancer . Participants complete questionnaire regard health smoking history . The investigator take blood sample , saliva sample , cheek cell urine measure exposure toxins harmful chemical present smokeless tobacco . Participants give smokeless tobacco study product ask use entire time study . The study product contains deuterated NNN . Deuterated NNN like NNN find commercially available smokeless tobacco product , label deuterium heavy hydrogen atom . Deuterium non-toxic safe . Using smokeless tobacco contain deuterium allow u follow NNN break body .</brief_summary>
	<brief_title>Metabolism Deuterated NNN Smokeless Tobacco Users</brief_title>
	<detailed_description>Fifty healthy smokeless tobacco user recruit advertise Minneapolis-St. Paul area . This research conduct Tobacco Research Center University Minnesota . Regular smokeless tobacco user screen phone . If eligible phone screen , participant invite attend orientation visit clinic consent obtain subject fill form tobacco use medical history . Subjects determine eligible orientation visit return clinic baseline visit receive smokeless tobacco product instruct use study product return first lab session seven day later . Prior three lab session , subject collect urine 24 hour lead scheduled appointment . At lab session , participant use study product collect saliva tobacco juice regular interval . Participants also swab inside cheek cell blood drawn . Collected sample use characterize metabolic activation DNA binding NNN .</detailed_description>
	<mesh_term>Lobeline</mesh_term>
	<criteria>Regular smokeless tobacco user Good physical health unstable medical condition Stable good mental health , i.e. , currently experience unstable untreated psychiatric diagnosis , include substance abuse , determine DSMIV criterion , past six month Willing perform study activity blood sample drawn , saliva collection , urine collection , multiple clinic visit For female subject child bear potential , know pregnant nursing , plan become pregnant within next 12 month Provide write informed consent Using tobacco nicotine containing product Unstable medical condition Currently take medication affect relevant metabolic enzyme Not willing use switch smokeless tobacco brand use tobacco enrich [ pyridineD4 ] ( S ) NNN course study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>tobacco toxicant</keyword>
	<keyword>smokeless tobacco</keyword>
	<keyword>nitrosamines</keyword>
	<keyword>tobacco specific nitrosamines ( TSNAs )</keyword>
</DOC>